Hematology

  1. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

    1. Suxin Wan
    2. Qingjie Yi
    3. Shibing Fan
    4. Jinglong Lv
    5. Xianxiang Zhang
    6. Lian Guo
    7. Chunhui Lang
    8. Qing Xiao
    9. Kaihu Xiao
    10. Zhengjun Yi
    11. Mao Qiang
    12. Jianglin Xiang
    13. Bangshuo Zhang
    14. Yongping Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients

    1. Sophia Stanford
    2. Ashok Roy
    3. Catherine Rea
    4. Ben Harris
    5. Antony Ashton
    6. Sarah Mangles
    7. Tamara Everington
    8. Rayan Taher
    9. Daniel Burns
    10. Emily Arbuthnot
    11. Tom Cecil

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients

    1. Sabine Haggenburg
    2. Quincy Hofsink
    3. Birgit I. Lissenberg-Witte
    4. Annoek E.C. Broers
    5. Jaap A. van Doesum
    6. Rob S. van Binnendijk
    7. Gerco den Hartog
    8. Michel S. Bhoekhan
    9. Nienke J.E. Haverkate
    10. Judith A. Burger
    11. Joey H. Bouhuijs
    12. Gaby P. Smits
    13. Dorine Wouters
    14. Ester M.M. van Leeuwen
    15. Hetty J. Bontkes
    16. Neeltje A. Kootstra
    17. Sonja Zweegman
    18. Arnon P. Kater
    19. Mirjam H.M. Heemskerk
    20. Kaz Groen
    21. Tom van Meerten
    22. Pim G.N.J. Mutsaers
    23. Tim Beaumont
    24. Marit J. van Gils
    25. Abraham Goorhuis
    26. Caroline E. Rutten
    27. Mette D. Hazenberg
    28. Inger S. Nijhof

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Effectiveness of convalescent plasma therapy in COVID-19 patients with haematological malignancies

    1. Sapha Shibeeb
    2. Ilham Ajaj
    3. Hadeel Al-Jighefee
    4. Atiyeh Abdallah

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Antibody responses to SARS‐CoV ‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies

    1. Wei Yee Chan
    2. Catherine Zhu
    3. Emilie Sanchez
    4. Rajeev Gupta
    5. Adele K. Fielding
    6. Asim Khwaja
    7. Elspeth M. Payne
    8. Jenny O'Nions

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19

    1. Steffen M Recktenwald
    2. Greta Simionato
    3. Marcelle GM Lopes
    4. Fabia Gamboni
    5. Monika Dzieciatkowska
    6. Patrick Meybohm
    7. Kai Zacharowski
    8. Andreas von Knethen
    9. Christian Wagner
    10. Lars Kaestner
    11. Angelo D'Alessandro
    12. Stephan Quint

    • Curated by eLife

      eLife assessment

      This report illustrates the marked alteration of red blood cell (RBC) morphology that occurs with COVID-19 infection. Of particular importance is the observation that RBC morphology is dramatically affected whether cells are suspended in plasma from healthy vs COVID-infected blood. The claims of the manuscript are well supported by the data, and the approaches used are thoughtful and rigorous. The results are important for consideration of the broader pathophysiology of COVID-19, particularly with regard to the impact on vascular biology.

    Reviewed by eLife, ScreenIT

    4 evaluationsAppears in 2 listsLatest version Latest activity

  7. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era

    1. Carsten U. Niemann
    2. Caspar da Cunha-Bang
    3. Marie Helleberg
    4. Sisse R. Ostrowski
    5. Christian Brieghel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Use of Convalescent Plasma Therapy with Best Available Treatment (BAT) among Hospitalized COVID-19 Patients: A Multi-Center Study

    1. Flordeluna Mesina
    2. Jomell Julian
    3. Jesus Relos
    4. Rosalio Torres
    5. Maureen Via M. Comia
    6. June Marie P. Ongkingco
    7. Jimmy R. Lafavilla

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response

    1. Paola Storti
    2. Valentina Marchica
    3. Rosanna Vescovini
    4. Valentina Franceschi
    5. Luca Russo
    6. Laura Notarfranchi
    7. Vincenzo Raimondi
    8. Denise Toscani
    9. Jessica Burroughs Garcia
    10. Federica Costa
    11. Benedetta Dalla Palma
    12. Nicolas Thomas Iannozzi
    13. Gabriella Sammarelli
    14. Gaetano Donofrio
    15. Nicola Giuliani

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Narratives of the convalescent plasma donor in a Peruvian social security hospital.: motivations, fears, expectations and experiences

    1. Silvana M. Matassini Eyzaguirre
    2. Christian Villanueva Yapa
    3. Ausberto Chunga Chunga
    4. Arturo Sagastegui Soto
    5. Ibeth Melania Neyra Vera
    6. Suly Soto Ordoñez
    7. Martina Guillermo Román
    8. Martin Oyanguren Miranda
    9. Percy Soto-Becerra
    10. Leda Yamileé Hurtado Roca
    11. Jorge L. Maguiña
    12. Araujo-Castillo Roger Vladimir

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 2 of 8 Next